Instrument Business Outlook Volume 31 - Issue 17
16 Dec 2022
Categories:
Instrument Business Outlook
Table of Contents
-
Lab Tool M&A Active in 2022 Despite Rising Interest Rates
- General M&A Environment
- Largest Deals Scaled Back
- Technology Targets
- Multiple Acquisitions
- Private Equity Firms
- Conclusion
-
Major New Lab Investments for Public Health and Personal Care
- French Firm Invests in the US
- US State Replaces a Public Health Lab
- New Lab Building to House Interdisciplinary Studies
- European University Announces New Life Science Lab
- Agricultural Labs Gets Funding
-
Executive Briefing
- EU Notifies Illumina of Divestment Plans for $8 Billion Purchase of Grail
- MilliporeSigma Buys Micro-Bioreactor Firm
- Molecular Devices Invests in Organoids
- Maravai Resolves CEO Dispute
- Shimadzu Makes Acquisition to Enhance MS business
- Sartorius Buys 10% of BICO
- Sample Prep Company Sold
- More Consolidation Among EU Lab Suppliers
-
Third Quarter Results: Bio-Techne, Biotage, HORIBA, Pacific Biosciences and Shimadzu AMI
- Bio-Techne Begins Fiscal Year with Mixed Results
- Biotage Continues 2022 with Broad-Based Gains
- HORIBA's SI Segment Continues Sales Growth
- Pacific Biosciences Sales Tumble
- Shimadzu AMI’S Sales Decline in Europe
-
Market Profile: Electroporation
- Leading Vendors
- Largest Markets
- Instrument Cost
-
Industry Watch
- Chemicals
- Biopharma
- Government & Biotech
-
Region Watch
- EU
- UK
- Greece
-
News
-
Broad-Based Companies
- Company Announcements
-
Life Science Consumables
- Company Announcements
- Gene-Based Analysis
- Company Announcements
- Product Introductions
- Cell-Based Analysis
- Company Announcements
- Product Introductions
- Protein-Based Analysis
- Company Announcements
- Product Introductions
- Informatics
- Company Announcements
- Product Introductions
- Sales & Orders of Note
-
Materials Characterization
- Company Announcements
- Product Introductions
-
Broad-Based Companies
- Bottom Line